Author Correction: Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion

Affiliations

• ¹ Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, 27708, USA.
• ² Center for Applied Genomics and Precision Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
• ³ Durham Veterans Affairs Health Care System, Durham, NC, 27705, USA.
• ⁴ Division of Infectious Diseases, School of Medicine, Duke University Medical Center, 40 Duke Medicine Circle, Durham, NC, 27710-4000, USA.
• ⁵ Department of Pharmacology and Cancer Biology, School of Medicine, Duke University, Durham, NC, 27710, USA.
• ⁶ Institute for Medical Research, Durham, NC, 27705, USA.
• ⁷ Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, 27710, USA.
• ⁸ Duke Human Vaccine Institute and Department of Medicine, School of Medicine, Duke University, Durham, NC, 27710, USA.
• ⁹ Department of Civil and Environmental Engineering, Pratt School of Engineering, Duke University, Durham, NC, 27708, USA.
• ¹⁰ Center for Applied Genomics and Precision Medicine, Duke University School of Medicine, Durham, NC, 27710, USA. chris.woods@duke.edu.
• ¹¹ Durham Veterans Affairs Health Care System, Durham, NC, 27705, USA. chris.woods@duke.edu.
• ¹² Division of Infectious Diseases, School of Medicine, Duke University Medical Center, 40 Duke Medicine Circle, Durham, NC, 27710-4000, USA. chris.woods@duke.edu.